Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
Clinical trial NCT04739527 · COMPLETED
Trial details
- NCT number
- NCT04739527
- Sponsor
- University Medical Center Groningen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2025-12-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.